PNC Managed Account Solutions’s United Therapeutics UTHR Stock Holding History

PNC Managed Account Solutions’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$17K	Buy	+94	New	+$17.9K	﹤0.01%	444

Other funds holding UTHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

PNC Managed Account Solutions's UTHR Position: Q2 2021 in Review

PNC Managed Account Solutions opened a new position in United Therapeutics (UTHR) in Q2 2021: 94 shares worth $17K. The stake represents ﹤0.01% of the portfolio and ranks #444 among its holdings.

402 funds tracked by Wall St. Rank hold UTHR as of Q2 2021.

PNC Managed Account Solutions held 94 shares of United Therapeutics worth $17K as of Q2 2021.
United Therapeutics was a new PNC Managed Account Solutions position in Q2 2021.
United Therapeutics made up ﹤0.01% of PNC Managed Account Solutions's portfolio in Q2 2021, its #444 holding.
402 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2021.

Based on PNC Managed Account Solutions's 13F filing for Q2 2021, filed 6 Aug 2021.